SAN JOSE, CA, September 21, 2026 /24-7PressRelease/ -- Ellie Masserrat has been selected for inclusion in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

Ms. Masserrat has established herself as a distinguished consultant in the field of digital transformation and life sciences at WinWire since 2024. Her role involves transitioning from clinical operations to clinical systems and introducing innovative tools and platforms to enhance overall operations within the regulated industry. Her expertise in clinical trial management is evident through her ability to break down complex tasks into manageable pieces, guide her team effectively, and maintain composure under pressure. Her commitment to learning and tackling challenges has been instrumental in her success.

Prior to her current position, Ms. Masserrat served as a clinical team manager at TriReme Medical/G Vascular from 2021 to 2024. Her responsibilities included overseeing clinical trials and ensuring compliance with regulatory standards. In 2024, she briefly held the role of clinical operations lead at Dexcom, focusing on wearable devices for persons with diabetes. Her experience at CVS Health from 2020 to 2021 as a consultant-study manager and clinical trial operations manager involved working on the Johnson & Johnson COVID-19 vaccine, where she played a crucial role in implementing a new business model to expedite the vaccination process.

From 2017 to 2020, Ms. Masserrat was a clinical trial manager in cardiology at HeartFlow Inc., where she contributed to the development of innovative technology using CT scans to create 3D models of the heart. Her earlier career includes a position as a senior clinical research specialist in coronary and structural heart at Medtronic from 2016 to 2017, where she was involved in Phase III clinical trials for a catheter device. She also worked as a clinical project manager at Catalent Pharma Solutions in 2016 and as a project manager for oncology clinical trials at Signant Health from 2011 to 2016.

Ms. Masserrat's academic achievements have significantly contributed to her professional success. She holds a Master of Business Administration in health care from George Washington University, completed in 2024, and a Graduate Certificate in Regulatory Affairs from the same institution. Her foundational education includes a degree in biochemistry and molecular biology from Pennsylvania State University, where she made the Dean's List in 2010. Additionally, she holds an ICSB Creativity & Innovation Certificate obtained in 2020.

Her involvement with industry-related organizations, such as the Society of Clinical Research Associates and the National Society of Leadership and Success, underscores her commitment to professional development. Ms. Masserrat's passion for collaboration is evident through her engagement with diverse individuals across various backgrounds, fostering an environment of positivity and motivation.

Beyond her professional endeavors, Ms. Masserrat is actively involved in civic associations and community projects. She volunteers with Hunger at Home and contributes to Prize LLC's project team. Her dedication extends to assisting veterans transitioning to civilian life through startup initiatives. Her publication, "The Student Experience of Attending the 33rd Annual PDA/FDA Joint Regulatory Conference: Insights into Biologics Manufacturing," reflects her commitment to sharing knowledge within her field.

In her personal life, Ms. Masserrat enjoys traveling, arts and crafts, painting, and spending time with friends and family. She is contemplating furthering her education by pursuing either a PhD or specialized programs in leadership, driven by her passion for learning and the belief that there are always opportunities for education, growth, and advancement.

# # #